Stephanie Pearl
Corporate Officer/Principal chez Office of Technology Development
Profil
Prior to joining OTD, Stephanie was a Senior Clinical Research Contracts Associate at Dana-Farber Cancer Institute where she focused on all contractual matters associated with industry sponsored and industry supported clinical trials and related research.
Prior to joining academia, Stephanie served as Legal Counsel for several pharma/biotech companies.
Stephanie holds a Common Law degree from University of Ottawa, a Civil Law degree from the Université de Montreal and a B.Sc.
in Nutritional Sciences from McGill University.
Postes actifs de Stephanie Pearl
| Sociétés | Poste | Début |
|---|---|---|
Office of Technology Development
 Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | - |
Anciens postes connus de Stephanie Pearl
| Sociétés | Poste | Fin |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Consultant / Advisor | 30/11/2007 |
| PFIZER, INC. | Consultant / Advisor | 31/08/2003 |
Formation de Stephanie Pearl
| University of Ottawa | Undergraduate Degree |
| University of Montréal | Undergraduate Degree |
| McGill University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Finance |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |